KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Elevance Health (ELV) Shares Outstanding (Weighted Average) (2016 - 2025)

Elevance Health (ELV) has disclosed Shares Outstanding (Weighted Average) for 17 consecutive years, with $224.0 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) fell 3.32% to $224.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $224.0 million through Dec 2025, down 3.32% year-over-year, with the annual reading at $224.0 million for FY2025, 3.32% down from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $224.0 million at Elevance Health, roughly flat from $223.3 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $245.0 million in Q1 2021, with the low at $223.3 million in Q3 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $235.6 million, with a median of $236.2 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) dropped 1.19% in 2022, then fell 3.71% in 2025.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $243.8 million in 2021, then dropped by 1.56% to $240.0 million in 2022, then decreased by 1.71% to $235.9 million in 2023, then dropped by 1.78% to $231.7 million in 2024, then fell by 3.32% to $224.0 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $224.0 million, $223.3 million, and $225.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.